相关实验视频

Updated: Jun 10, 2026

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Published on: August 29, 2012

使用类似于大脑的内皮细胞分化来表征CS79iBRCA-n2 BRCA1突变患者衍生干细胞系

Natalie G Alexander¹, Kylie A Buchanan¹, Alexandra E Meyer¹

¹Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.

Frontiers in cell and developmental biology

|May 15, 2025

概括

BRCA1突变增加了大脑转移风险. 来自患者的干细胞模拟了血脑屏障,以研究这种倾向及其机制.

科学领域:

遗传学是一个遗传学.
神经科学是一个神经科学.
在瘤学瘤学.

背景情况:

BRCA1/2基因是瘤抑制剂,对DNA修复至关重要.
致病性BRCA1/2突变是导致乳腺癌和卵巢癌的主要遗传原因.
BRCA1突变与潜在的无法治愈的大脑转移的风险增加有关.

研究的目的:

来自具有BRCA1突变的侵袭性癌症患者的人类诱导多能干细胞 (hiPSC) 线的特征.
在BRCA1相关的大脑转移的背景下,研究患者衍生的hiPSCs在研究血脑屏障 (BBB) 特性方面的实用性.

主要方法:

来自BRCA1突变患者的hiPSC线的生成和表征.
将hiPSCs分化为类似大脑的内皮细胞 (BECs).
在衍生 BEC 中评估 BBB 标记体的表达 (密集结蛋白,排放输送物).

主要成果:

患者衍生hiPSC线路的成功特征.
从这个hiPSC线区分出来的BEC表达了关键的BBB标记.
该模型显示了研究BRCA1突变载体中的BBB完整性的潜力.

结论:

来自患者的hiPSC模型提供了一个平台,用于调查BRCA1突变载体中BBB破坏的遗传倾向.
这种方法可以帮助阐明这些患者脑转移背后的分子机制.
未来的研究可以利用这些模型来确定预防或治疗大脑转移的治疗点.

关键词:

这是一种BRCA1突变.血脑屏障是什么意思大脑内皮细胞是脑内皮细胞.疾病建模疾病建模诱导多能干细胞的诱导干细胞.患者衍生干细胞患者衍生干细胞

更多相关视频

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype

Differentiation of Human Induced Pluripotent Stem Cells to Brain Microvascular Endothelial Cell-Like Cells with a Mature Immune Phenotype

Published on: May 19, 2023

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...